Investment Rating - The report maintains an "Accumulate" investment rating for the company, indicating a potential increase in stock price relative to the market index [1][4][7] Core Views - The company achieved an operating revenue of 182.069 billion yuan in 2024, representing a year-on-year growth of 3.38%, while the net profit attributable to the parent company was 13.033 billion yuan, down 22.49% year-on-year [4][6] - The company is actively addressing global economic uncertainties by enhancing its global channel layout and improving operational efficiency through digitalization [4][6] - The company has a robust project pipeline, including new materials and fine chemicals, which supports long-term growth prospects [4][6] Summary by Sections Financial Performance - In 2024, the company reported a polyurethane sales volume of 5.64 million tons, up 15.34% year-on-year, and a petrochemical product sales volume of 5.47 million tons, up 15.89% year-on-year [4][6] - The average price for pure MDI and polymer MDI in 2024 was 19,037 yuan/ton and 17,297 yuan/ton, reflecting a year-on-year decrease of 5.28% and an increase of 8.18%, respectively [4][6] - The overall gross profit margin for the year was 16.16%, down 0.61 percentage points year-on-year, primarily due to increased R&D expenses and significant impairment losses [4][6] Future Outlook - The company expects earnings per share (EPS) of 4.53 yuan and 5.73 yuan for 2025 and 2026, respectively, with corresponding price-to-earnings (PE) ratios of 12.42 and 9.82 based on the closing price of 56.26 yuan on April 15 [4][6] - The company is focusing on expanding its fine chemicals and new materials business, with several projects set to launch, including a 20,000-ton POE and a 48,000-ton citral facility [4][6] - The report highlights the company's transition from a polyurethane leader to a major player in new materials, leveraging its petrochemical business for competitive advantages [4][6]

Investment Rating - The report maintains an "Accumulate" investment rating for the company, indicating a potential increase in stock price relative to the market index [1][4][7]. Core Insights - The company achieved an operating revenue of 182.069 billion yuan in 2024, representing a year-on-year growth of 3.38%. However, the net profit attributable to the parent company was 13.033 billion yuan, down 22.49% year-on-year [4][6]. - The first quarter of 2025 saw a decline in revenue to 43.068 billion yuan, a decrease of 6.70% year-on-year, with net profit dropping 25.87% to 3.082 billion yuan [4][6]. - The company is actively addressing global economic uncertainties by enhancing its global channel layout and improving operational efficiency through digital resource investments [4][6]. Summary by Sections Financial Performance - In 2024, the company reported a polyurethane sales volume of 5.64 million tons, up 15.34% year-on-year, and a petrochemical product sales volume of 5.47 million tons, up 15.89% year-on-year [4][6]. - The average prices for key products such as pure MDI and polymer MDI fell by 5.28% and rose by 8.18%, respectively, while TDI and soft foam polyether prices decreased by 20.09% and 9.55% [4][6]. - The overall gross margin for the year was 16.16%, down 0.61 percentage points from the previous year, primarily due to increased R&D expenses and significant impairment losses [4][6]. Future Outlook - The company has a robust pipeline of new projects, including the production of 200,000 tons of POE and 48,000 tons of citral, which are expected to contribute to future growth [4][6]. - Earnings per share (EPS) for 2025 and 2026 are projected to be 4.53 yuan and 5.73 yuan, respectively, with corresponding price-to-earnings (PE) ratios of 12.42 and 9.82 based on the closing price of 56.26 yuan on April 15 [4][6].

Investment Rating - The investment rating for the company is "Buy" (maintained) [1][6][17] Core Views - The company's performance in Q4 2024 was under pressure, but there is optimism for future performance recovery and long-term growth, supported by ongoing expansion in polyurethane capacity [6][8] - In 2024, the company achieved operating revenue of 182.07 billion yuan, a year-on-year increase of 3.83%, while net profit attributable to shareholders was 13.03 billion yuan, a year-on-year decrease of 22.49% [6][10] - The company is expected to benefit from the recovery in the chemical sector, with new projects set to drive revenue growth in the coming years [6][8] Financial Performance Summary - In Q4 2024, the company reported operating revenue of 34.47 billion yuan, down 19.49% year-on-year and 31.80% quarter-on-quarter, with a net profit of 1.94 billion yuan, down 52.83% year-on-year and 33.55% quarter-on-quarter [6][10] - For Q1 2025, the company achieved revenue of 43.07 billion yuan, a decrease of 6.70% year-on-year but an increase of 24.96% quarter-on-quarter, with a net profit of 3.08 billion yuan, down 25.87% year-on-year but up 58.89% quarter-on-quarter [6][10] - The company has revised its profit forecasts for 2025-2027, expecting net profits of 14.56 billion yuan, 17.39 billion yuan, and 20.44 billion yuan respectively, with corresponding EPS of 4.64 yuan, 5.54 yuan, and 6.51 yuan [6][10] Production Capacity and Market Position - As of the end of 2024, the company had an MDI production capacity of 3.8 million tons/year and TDI production capacity of 1.11 million tons/year, with plans for further expansion [8] - The company is expected to complete a 700,000 tons/year MDI capacity upgrade by Q2 2026 and a new 330,000 tons/year TDI project by May 2025 [8] - The company is positioned to continue its growth trajectory as a leading player in the global chemical industry [8]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1][6] Core Views - The company's Q4 performance was under pressure, but there is optimism for future performance recovery and long-term growth. The company is expected to benefit from the recovery in the chemical sector and the growth in domestic demand, with new projects contributing to revenue growth [6][8] - In 2024, the company achieved a revenue of 182.07 billion yuan, a year-on-year increase of 3.83%, but the net profit attributable to shareholders decreased by 22.49% to 13.03 billion yuan. The Q4 revenue was 34.47 billion yuan, down 19.49% year-on-year and 31.80% quarter-on-quarter [6][10] - The company plans to expand its polyurethane production capacity, with MDI capacity expected to reach 4 million tons per year and TDI capacity to reach 1.11 million tons per year by the end of 2024. New projects are anticipated to drive long-term growth [8][10] Financial Summary - In 2024, the company reported a revenue of 182.07 billion yuan, with a year-on-year growth of 3.83%. The net profit attributable to shareholders was 13.03 billion yuan, down 22.49% year-on-year. The projected net profits for 2025, 2026, and 2027 are 14.56 billion yuan, 17.39 billion yuan, and 20.44 billion yuan respectively [6][10] - The company's gross margin for 2024 was 16.2%, with a net margin of 7.2%. The projected EPS for 2025, 2026, and 2027 are 4.64 yuan, 5.54 yuan, and 6.51 yuan respectively [10][13] - The company has a total market capitalization of 176.64 billion yuan, with a current stock price of 56.26 yuan, reflecting a P/E ratio of 12.1 for 2025 [1][10]

事件：万华化学发布2024 年年报和2025 年一季报，24FY 公司实现营业收入1820.69 亿元，同比+4%， 实现归母净利润130.33 亿元，同比-22%，公司每股派发现金红利人民币0.73 元（含税）。25Q1 公司实 现营业收入430.68 亿元，同比-7%，实现归母净利润30.82 亿元，同比-26%。 万华化学于2025 年4 月10 日成功收购法国康睿（Vencorex）的特种异氰酸酯业务。 25Q1 总体量增价减，价差走弱业绩承压，出口MDI 转弱，TDI 以价换量。 据公告，25Q1 聚氨酯、石化、新材料板块销量同比+11%/-1%/+23%，均价同比-5%/-11%/-2%，一季度 公司主要产品销量同比增长，但受产品价格下跌影响业绩承压。价差方面，25Q1 公司MDI/TDI/硬泡聚 醚价差同比+10%/-25%/-10%，环比-1%/持平/+2%，其中MDI/TDI 25Q1 价差时间百分比分位为 56%/11%，同比+17pct/-22pct，环比-2pct/持平，MDI 盈利维持相对高位；石化C3&C4/C2 平台综合价差 同比-8%/+10%，环比+8%/-17%，新材料板块 ...

Investment Rating - The report maintains a "Recommended" rating for the company, indicating a positive outlook for its future performance [4][7]. Core Views - The company reported a sales revenue of 182.07 billion yuan in 2024, a year-on-year increase of 3.83%, but the net profit attributable to shareholders decreased by 22.49% to 13.03 billion yuan [1]. - In Q1 2025, the company achieved a sales revenue of 43.07 billion yuan, a year-on-year decline of 6.70%, while the net profit attributable to shareholders fell by 26.33% to 3.04 billion yuan [1]. - The company continues to see steady growth in product sales across its three main segments: polyurethane, petrochemicals, and fine chemicals, with significant year-on-year increases in 2024 [2]. Summary by Sections Financial Performance - In 2024, the company achieved a total sales revenue of 182.07 billion yuan, with a net profit of 13.03 billion yuan, reflecting a decline in profitability [1][6]. - The forecast for 2025 estimates a revenue increase to 228.09 billion yuan, with a projected net profit of 12.19 billion yuan, indicating a continued decline in profitability [6][10]. Product Sales - The company reported strong sales growth in 2024, with polyurethane sales reaching 5.64 million tons (up 15.34%), petrochemical sales at 5.47 million tons (up 15.89%), and fine chemicals and new materials at 2.04 million tons (up 27.67%) [2]. - In Q1 2025, sales volumes showed mixed results, with polyurethane at 1.45 million tons (up 8.09%), while petrochemicals and fine chemicals experienced slight declines [2]. Research and Development - The company has made significant advancements in R&D, optimizing production processes and launching new technologies, which have helped maintain its competitive edge in the global market for MDI and TDI products [3]. - New production facilities have been established, including the world's largest single-unit capacity for POCHP, enhancing the company's production capabilities [3]. Market Position and Future Outlook - The company is positioned as a leader in the domestic chemical industry, with plans to expand its MDI capacity to 4.5 million tons by 2026 and TDI capacity to 1.44 million tons by mid-2025 [4]. - The investment outlook remains positive, with projected net profits for 2025-2027 estimated at 12.19 billion, 13.64 billion, and 15.99 billion yuan, respectively, indicating a recovery trend in profitability [4][6].

万华化学（600309.SH）2024 年年报及 2025 年一季报点评 盈利水平承压，年度销量稳步增长 2025 年 04 月 16 日 ➢ 事件：2025 年 4 月 14 日，万华化学发布 2024 年年报及 2025 年一季度报 告。2024 年实现销售收入 1820.69 亿元，同比增长 3.83%，实现归母净利润 130.33 亿元，同比-22.49%，实现扣非归母净利润 133.59 亿元，同比-18.74%。 2025 年一季度实现销售收入 430.68 亿元，同比-6.70%，环比+24.96%；实现 扣非归母净利润 30.40 亿元，同比-26.33%，环比 25.07%。 ➢ 2024 年产品销量保持较高增速，25Q1 销量环比有所下滑。聚氨酯、石化、 精细化学品及新材料三大板块产销量保持稳步增长。其中，聚氨酯系列产品 2024 年实现销量 564 万吨万吨，同比+15.34%，石化系列产品实现销量 547 万吨， 同比+15.89；精细化学品及新材料实现销量 204 万吨，同比+27.67%。2025 年 Q1，聚氨酯系列产品实现销量 145 万吨，同比+8.09%，环比-5.84%； ...

Investment Rating - The report maintains a "Buy" rating for the company, expecting a price increase of over 15% in the next 6-12 months [5][14]. Core Insights - In 2024, the company achieved revenue of 182.069 billion RMB, a year-on-year increase of 3.83%, while the net profit attributable to shareholders was 13.033 billion RMB, a decrease of 22.49% [2]. - For Q1 2025, the company reported revenue of 43.068 billion RMB, down 6.70% year-on-year, with a net profit of 3.082 billion RMB, down 25.87% [2]. - The company’s various business segments are performing stably, with polyurethane sales revenue at 75.844 billion RMB and a gross margin of 26.15% in 2024 [4]. Financial Performance Summary - Sales expenses increased by 20.25% year-on-year to 1.619 billion RMB in 2024, driven by the expansion of marketing and logistics efforts [3]. - Management expenses rose by 23.38% to 3.023 billion RMB, reflecting increased personnel costs [3]. - R&D expenses grew by 11.51% to 4.550 billion RMB, indicating ongoing technological upgrades [3]. - Asset impairment losses surged by 446.94% to 740 million RMB, primarily due to inventory write-downs and fixed asset impairments [3]. Segment Performance - The polyurethane segment is expected to expand its MDI capacity to 4.5 million tons per year by mid-2026, with a current capacity of 3.8 million tons [4]. - The petrochemical segment generated sales of 72.518 billion RMB in 2024, with a gross margin of 3.52% [4]. - The fine chemicals and new materials segment reported revenue of 28.273 billion RMB, with a gross margin of 12.78% [4]. Profit Forecast and Valuation - The projected net profits for 2025, 2026, and 2027 are 13.970 billion RMB, 14.636 billion RMB, and 15.804 billion RMB, respectively, with corresponding EPS of 4.45, 4.66, and 5.03 RMB per share [5]. - The current market valuation corresponds to P/E ratios of 12.64X, 12.07X, and 11.18X for the years 2025, 2026, and 2027 [5].

（原标题：今日，重要发布会，事关经济！） 重要新闻 多项经济数据将公布，国新办今日上午10时将举行新闻发布会，介绍2025年一季度国民经济运行情况。 中国人民银行会同金融监管总局、中国证监会、国家外汇局联合印发《金融"五篇大文章"总体统计制度（试行）》。 工业和信息化部组织制定的强制性国家标准《电动汽车用动力蓄电池安全要求》日前发布。 3．外交部发言人林剑15日表示，消博会、广交会、中国发展高层论坛等活动的成功举行，展现了各方加强经贸合作，抵御单边主义、保护主义的 决心和信心。中国是世界的市场、各国的机遇，将以高质量发展和高水平对外开放为世界经济注入稳定性和正能量。 4．社会保险基金监管局发布2024年全国职业年金基金市场化投资运营情况。截至2024年年底，全国31个省（自治区、直辖市）、新疆生产建设兵 团和中央单位职业年金基金投资运营规模3.11万亿元。自2019年2月启动市场化投资运营以来，全国职业年金年均投资收益率4.42%。 5．4月15日，海关总署召开进出口企业、行业协会商会座谈会。会上，进出口企业和行业协会商会负责人介绍了企业、行业生产运行和稳订单拓 市场情况，并提出政策措施建议。大家一致表示，坚 ...

丨证券研究报告丨 [Table_Title] 核心业务稳健运行，减值报废及 BC 有所拖累 报告要点 [Table_Summary] 公司发布 2024 年报及 2025 一季报，2024 年度实现收入 1820.7 亿元，同比变动+3.8%，归属 净利润 130.3 亿元，同比变动-22.5%，归属扣非净利润 133.6 亿元，同比变动-18.7%。2025Q1 实现收入 430.7 亿元，同比变动-6.7%，环比变动+25.0%，归属净利润 30.8 亿元，同比变动- 25.9%，环比变动+58.9%，归属扣非净利润 30.4 亿元，同比变动-26.3%，环比变动+25.1%。 分析师及联系人 [Table_Author] 马太 王明 SAC：S0490516100002 SAC：S0490521030001 SFC：BUT911 SFC：BVA881 请阅读最后评级说明和重要声明 %% %% %% %% research.95579.com 公司研究丨点评报告丨万华化学（600309.SH） 万华化学（600309.SH） cjzqdt11111 [Table_Title2] 核心业务稳健运行，减值报废 ...